SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported) November 30, 2000
-------------------------------
AMERIPATH, INC.
-------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
-------------------------------------------------------------------------------
(State or other jurisdiction of incorporation)
000-22313 65-0642485
-------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
7289 Garden Road
Suite 200
Riviera Beach, Florida 33404
-------------------------------------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code (561) 845-1850
-----------------------------
N/A
-------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On November 30, 2000, Ameripath, Inc. (the "Company") completed and
consummated the previously announced acquisition of Pathology Consultants of
America, Inc., d/b/a Inform DX ("Inform DX"). In connection with the
acquisition, the Company issued approximately 2.6 million shares of common stock
in exchange for all the outstanding common stock of Inform DX. In addition, the
Company assumed certain obligations to issue shares of common stock pursuant to
outstanding Inform DX stock option plans. This transaction will be accounted for
as a pooling of interests.
A copy of the press release, dated December 1, 2000, issued by the
Company, relating to the above-described transaction is attached as an Exhibit
to this report and incorporated herein by reference.
2
<PAGE>
Item 7. Financial Statements, Pro Forma Financials and Exhibits
(c) Exhibits
Exhibit
Number Description
-------------------------------------------------------------------------------
99.1 Press release, dated December 1, 2000, announcing that the
Company has completed the acquisition of Inform DX.
-------------------------------------------------------------------------------
3
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
AMERIPATH, INC.
Dated: December 7, 2000 By:/s/ Robert P. Wynn
-------------------------------
Robert P. Wynn
Executive Vice President and
Chief Financial Officer
4
<PAGE>
INDEX TO EXHIBITS
Exhibit
Number Description
-------------------------------------------------------------------------------
99.1 Press release, dated December 1, 2000, announcing that the
Company has completed the acquisition of Inform DX.
-------------------------------------------------------------------------------
